Summary & Overview

Prematurity with Major Problems: Inpatient Reimbursement Overview

DRG 791 addresses premature neonates with major medical complications requiring intensive neonatal care; its clinical scope includes severe respiratory, infectious, neurologic, and organ-system problems. Assignment to this Diagnosis-Related Group is important for inpatient reimbursement because it denotes higher resource utilization and typically results in increased Medicare payments compared with lower-severity neonatal groups.

Prematurity with Major ProblemsDRG Prematurity with Major ProblemsDRG 791Diagnosis-Related GroupInpatient ReimbursementMedicareNeonatologyNeonatal Intensive CareRespiratory Distress SyndromeNeonatal Sepsis

DRG 791 Overview

DRG 791 covers premature neonates with major problems that require significant medical intervention, such as respiratory distress syndrome, intraventricular hemorrhage, sepsis, or significant congenital anomalies. This Diagnosis-Related Group groups high-acuity neonatal cases to reflect greater resource use, intensive neonatal intensive care, and extended hospital stays. It matters for Medicare payment because classification into this Diagnosis-Related Group typically drives higher inpatient reimbursement to account for complex care needs and costly therapies. Accurate clinical documentation and coding determine assignment to this Diagnosis-Related Group and therefore affect billed inpatient payment.

Clinical Trials

Trials of acute neonatal respiratory and hemodynamic support strategies: randomized or pragmatic studies comparing different ventilatory modes (e.g., conventional vs. noninvasive ventilation strategies), surfactant administration timing/techniques, or short-term hemodynamic management protocols in very preterm infants with major complications such as respiratory distress syndrome, bronchopulmonary dysplasia risk, or patent ductus arteriosus. These studies enroll neonates born significantly preterm with major medical problems in NICUs and aim to define interventions that reduce immediate morbidity, duration of mechanical support, and short-term mortality. Results directly inform bedside protocols that affect length of stay, resource utilization, and early costs relevant to inpatient reimbursement and DRG assignment.
Comparative effectiveness and safety studies of infection prevention and management in high-risk preterm infants: observational cohort studies or randomized trials evaluating central line care bundles, antibiotic stewardship approaches, antifungal prophylaxis strategies, or diagnostic pathways for late-onset sepsis and necrotizing enterocolitis in preterm infants with major comorbidities. The population includes extremely and very preterm infants with complications who have prolonged NICU courses and high risk of nosocomial infections; the research question is which strategies reduce infection rates, antimicrobial exposure, and complications. Findings affect readmission rates, complication-driven resource use, and quality metrics that payers and hospitals monitor for cost and outcome optimization within this DRG.
Post-discharge outcomes and care coordination studies focusing on neurodevelopmental follow-up and resource utilization: longitudinal cohort studies or care-model trials that evaluate early intervention programs, structured follow-up clinics, or transitional care pathways to assess neurodevelopmental outcomes, rehospitalization rates, and healthcare utilization in infants born preterm with major problems. These studies follow survivors after NICU discharge—often up to 2–3 years corrected age—to capture developmental disability prevalence, need for therapies, and patterns of outpatient and inpatient service use. Evidence from this research guides discharge planning, outpatient resource allocation, and payer decisions about coverage for early intervention services that can influence long-term costs and outcomes for patients classified under this DRG.

Clinical Trials

Trials of acute neonatal respiratory and hemodynamic support strategies: randomized or pragmatic studies comparing different ventilatory modes (e.g., conventional vs. noninvasive ventilation strategies), surfactant administration timing/techniques, or short-term hemodynamic management protocols in very preterm infants with major complications such as respiratory distress syndrome, bronchopulmonary dysplasia risk, or patent ductus arteriosus. These studies enroll neonates born significantly preterm with major medical problems in NICUs and aim to define interventions that reduce immediate morbidity, duration of mechanical support, and short-term mortality. Results directly inform bedside protocols that affect length of stay, resource utilization, and early costs relevant to inpatient reimbursement and DRG assignment.
Comparative effectiveness and safety studies of infection prevention and management in high-risk preterm infants: observational cohort studies or randomized trials evaluating central line care bundles, antibiotic stewardship approaches, antifungal prophylaxis strategies, or diagnostic pathways for late-onset sepsis and necrotizing enterocolitis in preterm infants with major comorbidities. The population includes extremely and very preterm infants with complications who have prolonged NICU courses and high risk of nosocomial infections; the research question is which strategies reduce infection rates, antimicrobial exposure, and complications. Findings affect readmission rates, complication-driven resource use, and quality metrics that payers and hospitals monitor for cost and outcome optimization within this DRG.
Post-discharge outcomes and care coordination studies focusing on neurodevelopmental follow-up and resource utilization: longitudinal cohort studies or care-model trials that evaluate early intervention programs, structured follow-up clinics, or transitional care pathways to assess neurodevelopmental outcomes, rehospitalization rates, and healthcare utilization in infants born preterm with major problems. These studies follow survivors after NICU discharge—often up to 2–3 years corrected age—to capture developmental disability prevalence, need for therapies, and patterns of outpatient and inpatient service use. Evidence from this research guides discharge planning, outpatient resource allocation, and payer decisions about coverage for early intervention services that can influence long-term costs and outcomes for patients classified under this DRG.

OpenPayer

Summary & Overview

Prematurity with Major Problems: Inpatient Reimbursement Overview

DRG 791 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes